Nonalcoholic Fatty Liver Disease and Liver Transplantation

Tuan Pham, Travis B. Dick, Michael R. Charlton

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Nonalcoholic fatty liver disease (NAFLD) is prevalent in the general population and a growing indication for liver transplant. Longer wait times and challenges with pretransplant survivorship are expected, underscoring the need for improved management of attendant comorbidities. Recognition with potentiwal modification of obesity, sarcopenia, chronic kidney disease, and cardiovascular disease in patients with NAFLD may have important implications in the pretransplant and posttransplant periods. Although patients with NAFLD have generally favorable postoperative outcomes, they are at risk for developing recurrent disease in their allograft, driving the need for pharmacotherapies and dietary innovations appropriate for use in the posttransplant period.

Original languageEnglish (US)
Pages (from-to)403-417
Number of pages15
JournalClinics in Liver Disease
Issue number2
StatePublished - May 1 2016
Externally publishedYes


  • Liver transplantation
  • Nonalcoholic fatty liver disease
  • Nonalcoholic steatohepatitis
  • The metabolic syndrome

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Nonalcoholic Fatty Liver Disease and Liver Transplantation'. Together they form a unique fingerprint.

Cite this